http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011035001-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f9e3a1a81303dac8fbaa02c9a32c7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9862afea68af63b4d16468075d9e65ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f4d4e561f04e08f34e5b31c2e23bf60c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_18f8d30eb054371ac67a6c309e4162fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84ba7dbdacbcebda276e728bfd276c28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e870a9c94a283a44f399572407d0ca4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5161663a866745f7eac6fe04c42a19ba
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-236
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L29-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16
filingDate 2010-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8845fa9855697e6c2d2c006349ae6f61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1447bc06edf24d254bf832ba3dbada7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dff851220f8748428da3746dd1fb7639
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60f2791f52f88b97f043cccd038fa1bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8917b83c8a243648fdaefc1f9b666ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b552d9cc861e3dd9cecdefb82e2c3426
publicationDate 2012-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2011035001-A8
titleOfInvention Novel heparin entities and methods of use
abstract The present invention relates to immobilized biologically active entities that retain a significant biological activity following manipulation. The invention also comprises a medical substrate comprising a heparin entity bound onto a substrate via at least one heparin molecule, wherein said bound heparin entity is heparinase-1 sensitive.
priorityDate 2009-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414784756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22833565
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466

Total number of triples: 41.